Comprehensive dissection of rectal cancer organoids in responses to chemoradiation

The responses of cancer organoids to treatments in vitro can predict the clinical outcomes of corresponding patients. Here, we further uncover that the responses of cancer organoids to combined treatments predict the clinical outcomes of locally advanced rectal cancer (LARC) patients more faithfully than monotherapy with 92.50% and 93.75% accuracy in the discovery and validation cohorts, respectively, which is partly due to the synergistic (3.91%, 5/128) and antagonistic (4.69%, 6/128) treatment interactions in combined chemoradiation. In addition, our detailed analysis reveals that the time point for collecting survival data of organoids is critical to the efficacy of organoids' responses to treatments for predicting the clinical outcomes of LARC patients. Besides, our current data favor the addition of irinotecan for neoadjuvant treatment of LARC patients. The comprehensive dissection of rectal cancer organoids in responses to chemoradiation here may have significant implications for the broad application of organoids in cancer precision treatments.

Authors

Institutions

Publication Details

Journal
Cell Reports Medicine
Published
2025-10-01
DOI
https://doi.org/10.1016/j.xcrm.2025.102397
Citations
2
Primary Topic
Colorectal Cancer Surgical Treatments
Type
article
Field-Weighted Citation Impact
2.09

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comprehensive dissection of rectal cancer organoids in responses to chemoradiation

Peiyuan Tang, Guichao Li, Yuanchuang Li, Guoqiang Hua et al.
2 citations
Cell Reports Medicine
Colorectal Cancer Surgical Treatments
2.09
article

Comprehensive dissection of rectal cancer organoids in responses to chemoradiation

Peiyuan Tang, Guichao Li, Yuanchuang Li, Guoqiang Hua, Liping Liang, Xinxin Rao, Junjie Peng, Jianjun Gao, Guoxiang Fu, Qiang Guo, Ye Yao, Juefeng Wan, Hui Zhang, Min Chen, Jing Zhang, Yaqi Wang, Zhen Zhang, Xiaomeng Li, Sanjun Cai, Lijun Shen, Tao� Lv, Yi Zhou, Xiaoya Xu, Fan Xia, Xiaoxue Gao, Yun Deng, Mengxue Pan
article en
2 citations

Abstract

The responses of cancer organoids to treatments in vitro can predict the clinical outcomes of corresponding patients. Here, we further uncover that the responses of cancer organoids to combined treatments predict the clinical outcomes of locally advanced rectal cancer (LARC) patients more faithfully than monotherapy with 92.50% and 93.75% accuracy in the discovery and validation cohorts, respectively, which is partly due to the synergistic (3.91%, 5/128) and antagonistic (4.69%, 6/128) treatment interactions in combined chemoradiation. In addition, our detailed analysis reveals that the time point for collecting survival data of organoids is critical to the efficacy of organoids' responses to treatments for predicting the clinical outcomes of LARC patients. Besides, our current data favor the addition of irinotecan for neoadjuvant treatment of LARC patients. The comprehensive dissection of rectal cancer organoids in responses to chemoradiation here may have significant implications for the broad application of organoids in cancer precision treatments.

Cell Reports MedicineVol. 6(10)
Shanghai Medical College of Fudan University (CN), Fudan University Shanghai Cancer Center (CN), Institute of Applied Technology (CN)
Shanghai Anti-Cancer Association, National Natural Science Foundation of China, Langley Research Center
Openalex Percentile: Top 10%
Colorectal Cancer Surgical Treatments
2.09
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.